RU94045317A - Method for treatment of encephalomyelitis - Google Patents

Method for treatment of encephalomyelitis

Info

Publication number
RU94045317A
RU94045317A RU94045317/14A RU94045317A RU94045317A RU 94045317 A RU94045317 A RU 94045317A RU 94045317/14 A RU94045317/14 A RU 94045317/14A RU 94045317 A RU94045317 A RU 94045317A RU 94045317 A RU94045317 A RU 94045317A
Authority
RU
Russia
Prior art keywords
encephalomyelitis
treatment
patient
day
reaferon
Prior art date
Application number
RU94045317/14A
Other languages
Russian (ru)
Inventor
А.В. Дубов
В.П. Терещенко
О.И. Зайцева
Original Assignee
Институт медицинских проблем Севера СО РАМН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт медицинских проблем Севера СО РАМН filed Critical Институт медицинских проблем Севера СО РАМН
Priority to RU94045317/14A priority Critical patent/RU94045317A/en
Publication of RU94045317A publication Critical patent/RU94045317A/en

Links

Abstract

FIELD: medicine. SUBSTANCE: method involves drug therapy. The patient daily receives four 0.02 g doses of Quercitin for 21 days and 1,000,000 IU of Reaferon No. 10 by intramuscular injection every second day. . EFFECT: shorter period of treatment.

Claims (1)

Изобретение относится к области медицины, а именно к способам лечения энцефаломиелита, и может быть использовано для лечения вилюйского энцефаломиелита. Способ включает введение пациенту лекарственных препаратов. Новым в способе является то, что пациенту вводят кверцетин по 0,02 г в 4 приема в день в течение 21 дня и реаферон по 1 млн МЕ внутримышечно N 10 через день. Технический результат - сокращение сроков лечения.The invention relates to medicine, namely to methods for treating encephalomyelitis, and can be used to treat Vilyuy encephalomyelitis. The method includes administering drugs to a patient. New in the method is that the patient is administered quercetin at 0.02 g in 4 doses per day for 21 days and reaferon at 1 million IU intramuscularly N 10 every other day. The technical result is a reduction in treatment time.
RU94045317/14A 1994-12-27 1994-12-27 Method for treatment of encephalomyelitis RU94045317A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94045317/14A RU94045317A (en) 1994-12-27 1994-12-27 Method for treatment of encephalomyelitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94045317/14A RU94045317A (en) 1994-12-27 1994-12-27 Method for treatment of encephalomyelitis

Publications (1)

Publication Number Publication Date
RU94045317A true RU94045317A (en) 1996-10-27

Family

ID=48450210

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94045317/14A RU94045317A (en) 1994-12-27 1994-12-27 Method for treatment of encephalomyelitis

Country Status (1)

Country Link
RU (1) RU94045317A (en)

Similar Documents

Publication Publication Date Title
RU94027680A (en) Parathyroid hormone and raloxifen for bone mass increase, pharmaceutical composition and method of osseous mass increase
DE69132688T2 (en) METHOD FOR TREATING AND PREVENTING TYPE-1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
ES2144516T3 (en) PREPARATION WITH CONTROLLED RELEASE CONTAINING A MORPHINE SALT.
DE69230112D1 (en) ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE
FI971290A0 (en) Treatment of multiple sclerosis (MS) and other diseases caused by myelin loss
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
RU95101385A (en) Products containing g-csf and tnf-binding protein
DE69426471T2 (en) Use of sulodexide and medicines containing it to treat diabetic nephropathy
EP0290262A3 (en) Improved nitrate therapy for angina pectoris
RU2297233C1 (en) Method for treating glossalgia cases
ATE208201T1 (en) METHOD FOR TREATING NEOPLASTIC DISEASES USING TIAZOFURIN AND RIBAVIRIN
RU94045317A (en) Method for treatment of encephalomyelitis
SE9101341D0 (en) NEW MEDICINAL USE
RU95109221A (en) Method of interferon therapy
SU1666118A1 (en) Method for treatment of trifacial neurolgia
RU2099061C1 (en) Method for treating the cases of neurodermite
RU1822775C (en) Method for treatment of trigeminal nerve neuralgia
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
RU95106400A (en) Method of prevention and treatment of diphtheria neuropathy in experiment
RU94025799A (en) Method of treatment of idiopathic dermatomyositis
RU94037731A (en) Method for treating multiple sclerosis
RU95104039A (en) Method of vesical disease treatment
RU2002113429A (en) METHOD FOR TREATING PSORIASIS
RU94044515A (en) Nodular erythema treatment method
RU94015449A (en) Method for treating postoperative ophthalmosurgical complications